Even though evidence-based treatment for opioid use disorders (OUD) is effective, almost
four in five Americans with OUD do not receive any form of treatment. The gap in access to …

Background Opioid-related deaths have risen dramatically in rural communities. Prior
studies highlight few medication treatment providers for opioid use disorder in rural …

Objectives. We estimated national and state trends in opioid agonist medication-assisted
treatment (OA-MAT) need and capacity to identify gaps and inform policy decisions …

Importance Racial and ethnic disparities persist across key health and substance use
treatment outcomes for mothers and infants. The use of medications, such as methadone or …

At least 2.3 million people in the US have an opioid use disorder, less than 40% of whom
receive evidence-based treatment. Buprenorphine used as part of medication-assisted …

Background: Opioid use disorders (OUDs) are reaching epidemic proportions in the United
States, and many geographic areas struggle with a persistent shortage in availability of …

Background Maintenance treatments with medications for opioid use disorder (MOUD) are
highly effective at reducing overdose risk while patients remain in care. However, few …

Objectives During the COVID-19 pandemic, opioid treatment programs (OTPs) in the US
were granted new flexibility in methadone dispensing and the use of telemedicine. To …

Background and Objectives The opioid epidemic in the United States has resulted in a
public health emergency. Medication‐assisted treatment (MAT) with methadone and …

Your speech in the East Room of the White House, along with the remarks of the First Lady,
made it clear to the country that fighting this epidemic is a top priority of your Administration …